Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invitae Corp (NVTA)

Invitae Corp (NVTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,656,997
  • Shares Outstanding, K 95,175
  • Annual Sales, $ 147,700 K
  • Annual Income, $ -129,360 K
  • 60-Month Beta 2.51
  • Price/Sales 11.77
  • Price/Cash Flow N/A
  • Price/Book 5.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.52
  • Number of Estimates 5
  • High Estimate -0.43
  • Low Estimate -0.69
  • Prior Year -0.45
  • Growth Rate Est. (year over year) -15.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.86 +3.26%
on 10/18/19
21.97 -20.76%
on 09/23/19
-4.00 (-18.68%)
since 09/18/19
3-Month
16.86 +3.26%
on 10/18/19
28.75 -39.44%
on 08/07/19
-7.37 (-29.74%)
since 07/18/19
52-Week
9.04 +92.59%
on 12/24/18
28.75 -39.44%
on 08/07/19
+4.32 (+33.00%)
since 10/18/18

Most Recent Stories

More News
Invitae Corp Shares (NVTA)

SmarTrend identified a Downtrend for Invitae Corp (NYSE:NVTA) on September 4th, 2019 at $22.82. In approximately 1 month, Invitae Corp has returned 20.23% as of today's recent price of $18.20.

NVTA : 17.41 (-4.65%)
Research presented by Invitae at the American Society of Human Genetics Meeting Pushes Science and Practice of Genetics Forward

Researchers from Invitae Corporation (NYSE: NVTA), a leading medical genetics company, are presenting data showing the increasing utility of genetic information at the American Society of Human Genetics...

NVTA : 17.41 (-4.65%)
Invitae Corp (NVTA)

SmarTrend identified a Downtrend for Invitae Corp (NYSE:NVTA) on September 4th, 2019 at $22.82. In approximately 1 month, Invitae Corp has returned 16.98% as of today's recent price of $18.94.

NVTA : 17.41 (-4.65%)
Rough Start to Fourth Quarter

Rough Start to Fourth Quarter

QCOM : 77.68 (-1.63%)
CDAY : 44.74 (-1.95%)
LNG : 62.55 (+0.21%)
IPHI : 61.42 (-1.73%)
PODD : 153.74 (-1.75%)
PCRX : 38.85 (-0.18%)
SOXS : 34.83 (+3.45%)
NVTA : 17.41 (-4.65%)
MAXR : 7.68 (-0.90%)
Shares of NVTA Down 13.8% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Invitae Corp (NYSE:NVTA) on September 4th, 2019 at $22.82. In approximately 3 weeks, Invitae Corp has returned 13.78% as of today's recent price of $19.67.

NVTA : 17.41 (-4.65%)
Invitae (NVTA) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Invitae (NVTA) closed at $21.68, marking a -1% move from the previous day.

NVTA : 17.41 (-4.65%)
Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of Detect Hereditary Pancreatic Cancer, a testing program that offers no-charge genetic testing and counseling...

NVTA : 17.41 (-4.65%)
Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes

Invitae Corporation (NYSE: NVTA) announced the pricing on September 5, 2019 of $300.0 million aggregate principal amount of 2.00% convertible senior notes due 2024 (the "notes") in a private offering to...

NVTA : 17.41 (-4.65%)
Invitae Announces Proposed Offering of $200 Million of Convertible Senior Notes

Invitae Corporation (NYSE: NVTA) today announced its intention to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of convertible senior notes due 2024 (the...

NVTA : 17.41 (-4.65%)
Dow Jumps 1% Despite Yield Curve Worries

Dow Jumps 1% Despite Yield Curve Worries

A : 74.57 (-0.47%)
ABC : 89.64 (+0.16%)
CDNS : 65.60 (-0.61%)
BMY : 53.03 (+1.16%)
UNH : 245.34 (+0.69%)
CF : 47.77 (-1.42%)
MRTN : 21.59 (+0.33%)
NVTA : 17.41 (-4.65%)
GMS : 29.92 (unch)
TGT : 112.81 (-0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

See More Share

Trade NVTA with:

Business Summary

Invitae Corporation is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. It operates primarily in the United States, Israel and internationally. Invitae Corporation is headquartered in San Francisco, California.

See More

Key Turning Points

2nd Resistance Point 18.78
1st Resistance Point 18.09
Last Price 17.41
1st Support Level 16.79
2nd Support Level 16.18

See More

52-Week High 28.75
Fibonacci 61.8% 21.22
Fibonacci 50% 18.90
Last Price 17.41
Fibonacci 38.2% 16.57
52-Week Low 9.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar